the safety and efficacy of ketanserin , a competitive serotonin blocking agent , and propranolol were compared in 33 patients with mild to moderate hypertension ( sitting diastolic blood pressure [ dbp ] 95-115 mm hg ) using a placebo run-in , randomized , double-blind parallel study design .
C0033497
propranolol
C0020538
hypertension